检验医学 ›› 2012, Vol. 27 ›› Issue (4): 296-298.

• 免疫学检验论著 • 上一篇    下一篇

绝经后骨质疏松症患者性激素、细胞因子及骨代谢指标的变化及关系

易伟莲   

  1. 广东医学院附属医院,广东 湛江 524001
  • 收稿日期:2012-02-08 出版日期:2012-04-30 发布日期:2012-04-09
  • 作者简介:易伟莲,女,1963年生,副主任技师,主要从事临床医学检验工作。
  • 基金资助:

    广东省湛江市科技攻关项目(2010C3103013)

The changes and relationship with sex hormone, cytokine and bone metabolic marker of postmenopausal osteoporosis patients

  1. Affiliated Hospital of Guangdong Medical College, Guangdong Zhanjiang 524001, China
  • Received:2012-02-08 Online:2012-04-30 Published:2012-04-09

摘要: 目的  探讨绝经后骨质疏松症(POP)患者性激素、细胞因子及骨代谢指标的相关性。方法  根据腰椎骨密度(BMD)扫描结果将受试者分为3组,即POP组48例、绝经后非骨质疏松(NOP)组32例及绝经前健康对照组30名;采用放射免疫法、化学发光法及酶联免疫吸附试验(ELISA)测定110例受试者血清雌二醇(E2)、白细胞介素-6(IL-6)、胰岛素样生长因子-1(IGF-1)、骨碱性磷酸酶(BAP)及氨基端中段骨钙素(N-BGP)的水平,并进行相关性分析。结果  POP组患者血清IL-6、N-BGP及BAP水平增高,高于NOP组及正常对照组(P<0.01),而BMD和E2、IGF-1的水平则低于NOP组及正常对照组(P<0.01); IGF-1与BMD、E2呈显著正相关(r=0.572、0.436,P<0.01),与年龄呈显著负相关(r=-0.541,P<0.01);IL-6与BMD、E2呈负相关(r=-0.584、-0.435,P<0.05),与N-BGP、BAP呈正相关(r=0.546、0.354,P<0.05);BMD与IL-6、年龄、N-BGP、BAP呈负相关(P<0.05),与E2、IGF-1呈正相关(P<0.05)。结论  POP患者IL-6、N-BGP、BAP、E2及IGF-1水平可作为临床诊治POP的辅助指标。

关键词: 性激素, 细胞因子, 骨代谢指标, 骨质疏松, 绝经, 性激素, 细胞因子, 骨代谢指标, 骨质疏松, 绝经

Abstract: Objective  To investigate the correlation of sex hormone, cytokine and bone metabolic index in postmenopausal osteoporosis (POP) patients.  Methods  According to the results of the lumbar spine bone mineral density (BMD), the subjects were classified into 3 groups: POP group (48 cases), non-osteoporotic postmenopausal (NOP) group (32 cases) and premenopausal healthy group (30 cases). By radioimmunoassay, chemiluminescence and enzyme-linked immunosorbent assay (ELISA), sera of all 110 cases were tested for the levels of estradiol (E2), interleukin-6 (IL-6), insulin-like growth factor-1 ( IGF-1), bone alkaline phosphatase (BAP) and osteocalcin middle amino terminal (N-BGP), and the correlation was analyzed. Results  The levels of IL-6, N-BGP and BAP of POP group were increased and higher than those of NOP group and control group (P<0.01), while the BMD and the levels of E2 and IGF-1 of POP group were lower than those of NOP group and control group (P<0.01). IGF-1 with BMD and E2 showed a significant positive correlation (r=0.572 and 0.436, P<0.01), and IGF-1 was negatively correlated significantly with age (r=-0.541, P<0.01). IL-6 with BMD and E2 was negatively correlated (r=-0.584 and -0.435, P<0.05), and IL-6 with N-BGP and BAP was positively correlated (r=0.546 and 0.354, P<0.05). BMD with IL-6, age, N-BGP and BAP was negatively correlated (P<0.05), and BMD with E2 and IGF-1 was positively correlated (P<0.05). Conclusions  The levels of IL-6, N-BGP, BAP, E2 and IGF-1 may be indices of clinical diagnosis and treatment of POP.

Key words: Sex hormone, Cytokine, Bone metabolic index, Osteoporosis, Menopause, Sex hormone, Cytokine, Bone metabolic index, Osteoporosis, Menopause